Lynx.MD, a leading medical data intelligence platform, has announced a strategic partnership with Allied Digestive Health (ADH), a specialized care group under Assured Healthcare Partners (AHP). This collaboration is a significant step in expanding Lynx.MD’s gastroenterology data library, which is crucial for researchers and developers in the biopharma and MedTech sectors. The partnership allows Lynx.MD to access a vast array of specialized data from ADH, enhancing their gastroenterology real-world data resources, including imaging, video, and lab data. This data is pivotal for understanding the progression of various diseases and supports early detection and preventive care. It provides a rich data…
Author: Abhay Panchal
Dr. Neil Sharma has recently joined Peak Gastroenterology Associates in Colorado Springs, Colorado. Peak is known as the largest provider of gastroenterology and related services in the state. Dr. Sharma is a highly regarded board-certified, fellowship-trained interventional gastroenterologist and endoscopist. In his new role, he will lead Peak’s interventional program. Previously, Dr. Sharma was associated with Parkview Health in northeast Indiana, where he served for over a decade. His notable achievements include being the first President of the Parkview Cancer Institute, which he helped develop. Under his leadership, the institute was recognized in the top 100 by Becker’s Hospital Review…
Dr. Erica Barnell, Co-Founder & Chief Medical Officer of Geneoscopy, discusses the vital role of non-invasive diagnostics in preventing disease. This insightful conversation is a must-watch for anyone interested in the future of gastroenterology, digital health, and precision oncology. Highlights: Dr. Erica Barnell, a pioneer in medical science, brings her expertise to the forefront in this engaging interview. Get a glimpse into innovation reshaping the landscape of gastroenterology. Don’t miss this one.
A recent study published in “Annals of Oncology” by a French research group has made significant strides in precision medicine for treating metastatic colorectal cancer (mCRC). The study involved 110 mCRC patients treated with PD-L1 inhibitors, possibly combined with a CTLA-4 inhibitor. Researchers conducted DNA and RNA sequencing, adopting a discovery-and-validation approach to identify patients more responsive to immune checkpoint inhibitors. Traditionally, tumor mutational burden and microsatellite insufficiency were considered markers for response prediction. However, this study’s deep sequencing revealed that these markers were less significant. Instead, the researchers focused on genes associated with microsatellite instability (MSI) and a set…
Early detection of Barrett’s esophagus neoplasia is vital, managed through surveillance and BET (including EMR, ESD, RFA), but challenges like neoplasia identification and treatment resistance require tailored solutions.
In 2023, Medtronic reinforced its position in robotic surgery technology, particularly in gastroenterology and endoscopy, with its AI-driven GI Genius module gaining popularity and expanded partnerships.
This research represents a significant step in improving cancer diagnosis and treatment, potentially expanding the use of immunotherapy to a broader range of patients. Key Findings: Study Insights: Implications:
Throughout 2023, gastroenterology societies introduced several significant clinical practice updates for the diagnosis, management, and treatment of various gastrointestinal (GI) disorders, including celiac disease, inflammatory bowel disease, and acute liver failure. These updates emphasized the importance of noninvasive biomarkers, considered alpha-gal syndrome in unexplained GI symptoms, and introduced new recommendations for risk stratification and reversal agents in patients with liver failure on anticoagulants. Key Updates: These updates represent significant strides in gastroenterology and hepatology, offering more comprehensive and effective approaches to managing a range of GI disorders.
This study sheds light on the complex interplay between race, ethnicity, and cancer treatment outcomes, underscoring the importance of personalized medicine and the need for more inclusive research. Key Findings: Study Details: Implications:
The Bain & Company article discusses the impact of generative artificial intelligence (AI) on the healthcare industry, particularly in the context of private equity. Here are the key points: Potential of Generative AI in Healthcare: Generative AI is poised to significantly enhance productivity, improve patient and provider experiences, and lead to better clinical outcomes in healthcare. This technology stands out for its ability to create new content, summarize and translate existing content, and perform reasoning and planning tasks. Applications Across Healthcare Sectors: Collaborations and Investments: Long-term Potential: While healthcare often requires human labor and judgment, generative AI promises to address…